Research Article

Association of the changes in pulmonary artery diameters with clinical outcomes in hospitalized patients with COVID-19 infection: A crosssectional study

Volume: 35 Number: 3 October 31, 2022
  • Aybuke Selcuk *
  • Can Ilgın
  • Sait Karakurt
EN

Association of the changes in pulmonary artery diameters with clinical outcomes in hospitalized patients with COVID-19 infection: A crosssectional study

Abstract

Objective: Enlarged pulmonary artery diameter (PAD) can be associated with mortality risk in coronavirus disease 2019 (COVID-19) patients. Our aim is to find the factors that cause changes in PAD and the relationship between radiological findings and clinical outcomes in COVID-19 patients. Patients and Methods: In this descriptive, retrospective, and single centered study, among the hospitalized 3264 patients, 209 patients with previous chest computed tomography (CT) were included. Findings of current chest CTs of patients obtained during COVID-19 were compared with that of previous chest CTs. Pulmonary involvements, World Health Organization (WHO) Clinical Progression Scale scores and laboratory variables were recorded. Intensive Care Unit (ICU) admission, intubation and mortality were clinical outcomes that were evaluated by using uni – and multivariate analyses. Results: Patients with high D-dimer had significantly increased risk for enlarged PAD and increase in PAD compared to previous chest CT (ΔPAD) (OR=1.18, p<0.05, OR=1.2 p<0.05). Both high D-dimer and an increase over 2 mm in PAD (ΔPAD 2mm) had significant risks for ICU admission, intubation, and mortality (OR= 1.18 p<0.01, OR=1.22 p<0.01, OR=2.62 p<0.05, OR=2.12 p<0.01, OR=2.32 p<0.01, OR=2.09 p<0.001 respectively). It was found that with enlarged PAD, risk of ICU admission and mortality increased. (OR=3.03 p<0.001, OR=2.52 p<0.01). Combined with age and lymphocyte counts, PAD predicted mortality with a 50% sensitivity, 88% specificity (AUC=0.83, p<0.001). Conclusion: PPatients with an increase over 2 mm (ΔPAD 2mm) in PAD had significantly increased clinical severity, ICU admission, intubation, and mortality. High levels of D-dimer and CRP in patients suggest that increased inflammation and thrombosis may be effective in pathogenesis.

Keywords

References

  1. Suh YJ, Hong H, Ohana M, et al. Pulmonary embolism and deep vein thrombosis in COVID-19: A Systematic review and meta-analysis. Radiology 2021;298: 70-80. doi: 10.1148/ RADIOL.202.020.3557
  2. Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Heide RSV. Pulmonary and cardiac pathology in African American patients with COVID19: an autopsy series from New Orleans. The Lancet Respir Med 2020; 8, 681-9. doi: 10.1016/S2213- 2600(20)30243-5
  3. Jiménez D, García-Sanchez A, Rali P, et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis. Chest 2021;159, 1182-96. doi: 10.1016/j.chest.2020.11.005
  4. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med 2020; 46, 1089- 98. doi: 10.1007/s00134.020.06062-x Jevnikar M, Sanchez O, Chocron R, et al. Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission. Eur Respir J 2021;58:2100116. doi: 10.1183/13993.003.00116-2021
  5. D’Andrea, A, Scarafile R, Riegler L, et al. Right ventricular function and pulmonary pressures as independent predictors of survival in patients with COVID-19 Pneumonia. JACC: Cardiovasc Imaging 2020;13:2467-8. doi: 10.1016/j. jcmg.2020.06.004
  6. Jalde FC, Beckman MO, Svensson AM, et al. Widespread parenchymal abnormalities and pulmonary embolism on contrast-enhanced CT predict disease severity and mortality in hospitalized COVID-19 patients. Front Med 2021;8:666723. doi: 10.3389/fmed.2021.666723
  7. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. NEJM 2020; 38: 120-8. doi: 10.1056/nejmoa2015432
  8. Truong Q. A., Bhatia HS, Szymonifka J, et al. A fourtier classification system of pulmonary artery metrics on computed tomography for the diagnosis and prognosis of pulmonary hypertension. J Cardiovasc Comput Tomogr 2018; 12:60-6. doi: 10.1016/j.jcct.2017.12.001

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Authors

Aybuke Selcuk * This is me
0000-0002-2063-3468
Türkiye

Sait Karakurt This is me
0000-0002-6699-5798
Türkiye

Publication Date

October 31, 2022

Submission Date

June 16, 2022

Acceptance Date

August 27, 2022

Published in Issue

Year 2022 Volume: 35 Number: 3

APA
Selcuk, A., Ilgın, C., & Karakurt, S. (2022). Association of the changes in pulmonary artery diameters with clinical outcomes in hospitalized patients with COVID-19 infection: A crosssectional study. Marmara Medical Journal, 35(3), 355-361. https://doi.org/10.5472/marumj.1195539
AMA
1.Selcuk A, Ilgın C, Karakurt S. Association of the changes in pulmonary artery diameters with clinical outcomes in hospitalized patients with COVID-19 infection: A crosssectional study. Marmara Med J. 2022;35(3):355-361. doi:10.5472/marumj.1195539
Chicago
Selcuk, Aybuke, Can Ilgın, and Sait Karakurt. 2022. “Association of the Changes in Pulmonary Artery Diameters With Clinical Outcomes in Hospitalized Patients With COVID-19 Infection: A Crosssectional Study”. Marmara Medical Journal 35 (3): 355-61. https://doi.org/10.5472/marumj.1195539.
EndNote
Selcuk A, Ilgın C, Karakurt S (October 1, 2022) Association of the changes in pulmonary artery diameters with clinical outcomes in hospitalized patients with COVID-19 infection: A crosssectional study. Marmara Medical Journal 35 3 355–361.
IEEE
[1]A. Selcuk, C. Ilgın, and S. Karakurt, “Association of the changes in pulmonary artery diameters with clinical outcomes in hospitalized patients with COVID-19 infection: A crosssectional study”, Marmara Med J, vol. 35, no. 3, pp. 355–361, Oct. 2022, doi: 10.5472/marumj.1195539.
ISNAD
Selcuk, Aybuke - Ilgın, Can - Karakurt, Sait. “Association of the Changes in Pulmonary Artery Diameters With Clinical Outcomes in Hospitalized Patients With COVID-19 Infection: A Crosssectional Study”. Marmara Medical Journal 35/3 (October 1, 2022): 355-361. https://doi.org/10.5472/marumj.1195539.
JAMA
1.Selcuk A, Ilgın C, Karakurt S. Association of the changes in pulmonary artery diameters with clinical outcomes in hospitalized patients with COVID-19 infection: A crosssectional study. Marmara Med J. 2022;35:355–361.
MLA
Selcuk, Aybuke, et al. “Association of the Changes in Pulmonary Artery Diameters With Clinical Outcomes in Hospitalized Patients With COVID-19 Infection: A Crosssectional Study”. Marmara Medical Journal, vol. 35, no. 3, Oct. 2022, pp. 355-61, doi:10.5472/marumj.1195539.
Vancouver
1.Aybuke Selcuk, Can Ilgın, Sait Karakurt. Association of the changes in pulmonary artery diameters with clinical outcomes in hospitalized patients with COVID-19 infection: A crosssectional study. Marmara Med J. 2022 Oct. 1;35(3):355-61. doi:10.5472/marumj.1195539

Cited By